Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00900965
Other study ID # IBS_FBM
Secondary ID
Status Completed
Phase N/A
First received May 12, 2009
Last updated June 30, 2009
Start date April 2008
Est. completion date December 2008

Study information

Verified date June 2009
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Irritable bowel syndrome (IBS) is the most common digestive disorder that affects more than 5% of population in Hong Kong. However, there is no effective treatment of IBS using Western Medicine. Acupuncture, a traditional therapeutic modality, has been used in China for thousands of years for various pain disorders. In addition to analgesia, acupuncture has also been shown to influence physiology of gastrointestinal tract. The investigators set out to evaluate the therapeutic value of acupuncture in IBS. The investigators will study its effects on rectal sensation and brain activity in patients with IBS.

All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline assessment includes individual IBS symptoms (pain/discomfort, bloating, constipation, and diarrhea) as perceived by patients will be scored. The syndrome of IBS patients will also be recorded and analyzed based on the Chinese medicine theories. All patients will then undergo baseline rectal barostat for thresholds of rectal sensation. At visit 2, eligible patients will be randomly assigned to either (1) electroacupuncture or (2) sham electroacupuncture treatment groups. Functional Magnetic Resonance Imaging (fMRI) scanning will be performed before, during and after the electroacupuncture or sham electroacupuncture treatment.


Description:

All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline assessment includes the following items:

1. Global symptom assessment: Based on Rome III Working Group recommendation, a clinical outcome response measure is used in which patients are required to report "improved", "the same" or "worsened" to the question "Do you have adequate symptom relief in the past 7 days?"

2. Individual IBS symptoms: The individual IBS symptom (pain/discomfort, bloating, constipation, and diarrhea) as perceived by patients will be scored in a 5-point scale (0=none or asymptomatic; 1=mild with no limitation of normal activities; 2=moderate with limitation of some normal activities; 3=intense and unable to carry out most normal activities; 4=incapacitating symptom that are intolerable and unable to carry out all normal activities).

3. Syndrome of Chinese medicine: The syndrome of IBS patients will be recorded and analyzed based on the Chinese medicine theories. These symptoms involving: fatigue, appetite, sense of mouth, quality of sleep, the coating of tongue, pulse, etc.

4. Quality of life (QOL) assessment: A disease-specific questionnaire- IBS Quality of Life Scale (Chinese) will be used for assessment of QOL in response to treatment. The questionnaire was locally validated, and was recently developed by our group.

5. Rectal barostat: The patients will be evaluated for the sensory threshold and maximum tolerable threshold of rectum in response to balloon distension of rectum before the acupuncture treatment.

At visit 2, eligible patients will be randomly assigned to either (1) electroacupuncture or (2) sham electroacupuncture. During the treatment, the patient will receive fMRI to evaluate the cerebral cortical activity in response to balloon distension of rectum. Three sets of real-time functional brain mapping using fMRI will be performed during rectal balloon distensions at maximum tolerable pressure at the following time points:

1. 10 minutes after acupuncture needle insertion before delivery of electrical stimulation

2. 15 minutes after electrical stimulation begins (electrical stimulation continues during MRI)

3. Immediately after electrical stimulation stops before removal of acupuncture needle

Rectal barostat:

The barostat device contains a built-in computer system that can be programmed to automatically perform distensions of balloon with fixed time lags and bag pressure increments. Variation in balloon volume in a constant pressure reflects the change in tone and compliance of the visceral wall. Furthermore, through a programmed variation in intraballoon pressure, the sensory threshold of subject can be evaluated.

The patient is instructed to take low residue diet 2 days prior to barostat. On the day before barostat, bowel preparation is performed by ingestion of 4 liters of polyethylene glycol solution in 2 divided doses. After a 12-hour fast, the participant is positioned in supine position on MRI table. A barostat bag is inserted into the rectum. The barostat device is connected to the barostat catheter using a low compliance PVC tubing. The participant will remain alone in MRI cubicle during the whole experiment but a speaker and microphone system allows communication with the investigator. He/she is also provided a squeeze bulb to signify pain. Repeated squeezing of the bulb signifies request for termination of procedure.

Phasic isobaric rectal distensions are performed automatically using ascending method of limits (AML) protocol with successive increments of 4 mm Hg (40-second duration) alternating with intermittent periods of bag deflation (40 seconds). During each distension phase, the participant is requested to report the perception ratings by pressing on the perception panel of barostat device with the following scale: (1) no sensation (2) the first sensation of balloon distension, (3) desire for defecation, (4) maximum tolerable sensation. The procedure will be stopped when pain or maximum tolerable sensation is reported. The sensory threshold is defined as lower limit of the bag pressure that evokes the first sensation of balloon distension. The pain threshold is defined as pressure that elicits a "pain" response or maximum tolerable sensation.

Electroacupuncture Treatment:

Treatment will be performed by a single licensed acupuncturist. Both the patient and the investigator are unaware of the treatment assigned. A specially designed copper needle (0.22x4mm), which can be used safely in MRI suite, will be inserted through a plaster over the respective acupoints, under which a plastic ring will be positioned, connected with electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair) through wires with stimulation frequency of 150Hz, lasting for 30 minutes. For sham acupuncture, the needle will be positioned at 2cm away from the true respective acupoints., the same electric stimulation will be the same as real acupuncture treatment. The treatment will be given by an independent acupuncturist who is not involved in the data acquisition and analysis. Points for acupuncture treatment are chosen to regain the balance of liver qi stagnation and strengthen the spleen:

Anatomical location (Function according to TCM)

1. SP06:3cm above the medial malleolus dorsal tibial rim (Strengthens spleen and stomach)

2. ST25:2cm lateral to the umbilicus (Strengthens spleen and stop diarrhea)

3. ST36:5cm below patella, 2 cm lateral of the tibial rim (Strengthens spleen and stomach)

4. ST37:3cm below ST36 (Strengthens spleen and stop diarrhea)

Functional MRI:

BOLD imaging is performed with a 3-T MRI scanner (Philips Achieva 3.0T, X series, Quasar Dual MRI system). Each study consists of axial T1-weighted spin echo images (matrix of at least 192 × 256) covering the whole brain for anatomical correlation. Functional scan is performed using a single-shot echo planar pulse sequence in an interleaved multislice format with a field of view of 24 cm and a matrix size of at least 64 × 64, resulting in a in-plane resolution of 3.75 × 3.75. The pulse sequence parameters include a 90° flip-angle with a TE (time to echo)/TR (repetition time) of 60 ms/4000 ms. Each paradigm consists of 5 periods. Each period will consist of rest and stimulation (tube inflation causing rectal distension). In each period, 50 dynamics are performed. Each dynamic will last for 2 seconds. The scans will be performed with the rectal tube inflated to render:

1. Desire for defecation, and

2. Painful sensation, as determined by the barostat study at baseline visit within one week before MRI scanning.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Irritable bowel syndrome of diarrhea type as defined by Rome III criteria

- Age 18-65 years

- Normal colonic evaluation within 12 months (with either colonoscopy or barium study)

Exclusion Criteria:

- IBS-constipation, mixed or unsubtyped

- Pregnancy

- Medical history of organic colonic bowel disease

- History of sensitivity to acupuncture

- Psychiatric or additive disorder

- Patients who have received acupuncture in the past 6 months

- Concomitant medications including anti-diarrhea agent, anti-depressant, narcotic analgesic and anti-cholinergic

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Electroacupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
A specially designed copper needle (0.22 x 4 mm), which can be used safely in MRI suite, will be inserted through a plaster over the respective acupoints, under which a plastic ring will be positioned, connected with electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair) through wires with stimulation frequency of 150 Hz, lasting for 30 minutes.
Sham acupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
Needle will be positioned at 2 cm away from the true respective acupoints, with a blunted, telescopic placebo needle. The same electric stimulation will be the same as real acupuncture treatment.

Locations

Country Name City State
China The Chinese University of Hong Kong, Prince of Wales Hospital Shatin, Hong Kong

Sponsors (2)

Lead Sponsor Collaborator
Chinese University of Hong Kong National Institutes of Health (NIH)

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensory and pain thresholds as determined by rectal barostat At baseline study visit No
Primary Degree of cortical activation as determined by functional MRI At study visit 2 No
See also
  Status Clinical Trial Phase
Completed NCT03720314 - Microbiota Profiling in IBS
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT05213910 - Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains N/A
Recruiting NCT05985018 - Traditional Dietary Advice Vs. Mediterranean Diet in IBS N/A
Completed NCT04486469 - Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study. N/A
Completed NCT06407609 - Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS N/A
Completed NCT04656730 - Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas Phase 4
Completed NCT04145856 - Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico Phase 4
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Active, not recruiting NCT03586622 - One Year Home Monitoring and Treatment of IBS Patients N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT06369753 - Visible Abdominal Distension N/A
Not yet recruiting NCT05157867 - In Vivo Effects of Amylase Trypsin Inhibitors N/A
Not yet recruiting NCT05100719 - The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) N/A
Recruiting NCT05001997 - Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome N/A
Recruiting NCT02953171 - Probiotics in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT03266068 - Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Completed NCT02977975 - Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT02980406 - The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level N/A
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3